Jyong Biotech Ltd. Ordinary Shares
MENS | NASDAQ
$1.91
+$0.03 (+1.60%)
Nov 2, 2026, 10:51 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -61.72 | -254.66 | -174.61 | -115.94 | -183.15 | -377.24 |
PEG Ratio | -1.01 | 8.10 | 5.20 | -2 | -1.73 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -11.58 | -21.05 | -22.56 | -25.94 | -32.95 | -37.68 |
P/FCF Ratio | -94.84 | -212.10 | -295.52 | -238.93 | -362.39 | -615.78 |
P/OCF Ratio | -94.84 | -212.10 | -295.52 | -258.71 | -387.42 | -665.63 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.74 | -0.50 | -0.49 | -0.48 | -0.51 | -0.71 |
Quick Ratio | 0.45 | 0.02 | 0.13 | 0.19 | 0.42 | 1.08 |
Current Ratio | 0.45 | 0.02 | 0.13 | 0.19 | 0.42 | 1.08 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -1.03 | -1.99 | -3.69 | -3.70 | -2.88 | -2.94 |
Return on Equity | 18.75% | 8.27% | 12.91% | 22.38% | 18% | 9.98% |
Return on Assets | -22.48% | -47.42% | -53.35% | -75.81% | -44.51% | -14.92% |
Return on Invested Capital | 45.99% | -122.38% | -133.70% | -77.38% | -28.89% | -20.35% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MENS